These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 2229254)
1. Simultaneous determination of disopyramide and its mono-N-dealkylated metabolite enantiomers in human plasma and urine by enantioselective high-performance liquid chromatography. Takahashi H; Tamura A; Ogata H; Masuhara K J Chromatogr; 1990 Aug; 529(2):347-58. PubMed ID: 2229254 [TBL] [Abstract][Full Text] [Related]
2. Enantioselective analysis of disopyramide and mono-N-dealkyldisopyramide in plasma and urine by high-performance liquid chromatography on an amylose-derived chiral stationary phase. Bortocan R; Lanchote VL; Cesarino EJ; Bonato PS J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(2):299-306. PubMed ID: 10993518 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous determination of disopyramide and mono-N-dealkyldisopyramide enantiomers in plasma and urine by use of a chiral cellulose-derivative column. Echizen H; Ochiai K; Kato Y; Chiba K; Ishizaki T Clin Chem; 1990 Jul; 36(7):1300-4. PubMed ID: 2372941 [TBL] [Abstract][Full Text] [Related]
5. Enantioselective steady-state kinetics of unbound disopyramide and its dealkylated metabolite in man. Hasselström J; Enquist M; Hermansson J; Dahlqvist R Eur J Clin Pharmacol; 1991; 41(5):481-4. PubMed ID: 1761078 [TBL] [Abstract][Full Text] [Related]
6. Stereoselective disposition and metabolism of disopyramide in pediatric patients. Echizen H; Takahashi H; Nakamura H; Ochiai K; Chiba K; Koike K; Ogata H; Ishizaki T J Pharmacol Exp Ther; 1991 Dec; 259(3):953-60. PubMed ID: 1762088 [TBL] [Abstract][Full Text] [Related]
7. Liquid chromatographic analysis of disopyramide and its mono-N-dealkylated metabolite. Lima JJ Clin Chem; 1979 Mar; 25(3):405-8. PubMed ID: 262180 [TBL] [Abstract][Full Text] [Related]
8. Quantitative determination of disopyramide, verapamil and flecainide enantiomers in rat plasma and tissues by high-performance liquid chromatography. Hanada K; Akimoto S; Mitsui K; Hashiguchi M; Ogata H J Chromatogr B Biomed Sci Appl; 1998 Jun; 710(1-2):129-35. PubMed ID: 9686879 [TBL] [Abstract][Full Text] [Related]
9. Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans. Le Corre P; Gibassier D; Sado P; Le Verge R Drug Metab Dispos; 1988; 16(6):858-64. PubMed ID: 2907466 [TBL] [Abstract][Full Text] [Related]
10. Human pharmacokinetics and metabolism of disopyramide enantiomers. Le Corre P; Gibassier D; Sado P; Le Verge R Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():233-7. PubMed ID: 1820885 [TBL] [Abstract][Full Text] [Related]
11. Relationship between alpha 1-acid glycoprotein and distribution of disopyramide and mono-N-dealkyldisopyramide in whole blood. Bredesen JE; Kierulf P Br J Clin Pharmacol; 1986 Sep; 22(3):281-6. PubMed ID: 3768240 [TBL] [Abstract][Full Text] [Related]
12. Effects of serum concentrations of disopyramide and its metabolite mono-N-dealkyldisopyramide on the anticholinergic side effects associated with disopyramide. Tsuchishita Y; Fukumoto K; Kusumoto M; Ueno K Biol Pharm Bull; 2008 Jul; 31(7):1368-70. PubMed ID: 18591776 [TBL] [Abstract][Full Text] [Related]
13. Stereoselective biliary elimination of disopyramide and mono-N-desisopropyldisopyramide in humans. le Corre P; Malledant Y; Chevanne F; Sado P; le Verge R Chirality; 1992; 4(2):80-3. PubMed ID: 1616827 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of disopyramide in the dog. Importance of mono-N-dealkylated metabolite kinetics in assessing pharmacokinetic modeling of the parent drug. Cook CS; Gwilt PR; Kowalski K; Gupta S; Oppermann J; Karim A Drug Metab Dispos; 1990; 18(1):42-9. PubMed ID: 1970776 [TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of disopyramide and mono-N-dealkyldisopyramide enantiomers in human plasma by capillary electrophoresis. Jabor VA; Lanchote VL; Bonato PL Electrophoresis; 2001 Apr; 22(7):1406-12. PubMed ID: 11379964 [TBL] [Abstract][Full Text] [Related]
16. Determination of disopyramide and its mono-N-dealkylated metabolite in blood serum and urine. Hutsell TC; Stachelski SJ J Chromatogr; 1975 Mar; 106(1):151-8. PubMed ID: 1150784 [TBL] [Abstract][Full Text] [Related]
17. Comparison between two methods for the determination of the total and free (R)- and (S)-disopyramide in plasma using an alpha 1-acid glycoprotein column. Enquist M; Hermansson J J Chromatogr; 1989 Sep; 494():143-56. PubMed ID: 2584312 [TBL] [Abstract][Full Text] [Related]
18. Direct enantiomeric resolution of disopyramide and its metabolite using chiral high-performance liquid chromatography. Application to stereoselective metabolism and pharmacokinetics of racemic disopyramide in man. Le Corre P; Gibassier D; Sado P; Le Verge R J Chromatogr; 1988 Oct; 450(2):211-6. PubMed ID: 3235589 [TBL] [Abstract][Full Text] [Related]
19. Determination of unbound warfarin enantiomers in human plasma and 7-hydroxywarfarin in human urine by chiral stationary-phase liquid chromatography with ultraviolet or fluorescence and on-line circular dichroism detection. Takahashi H; Kashima T; Kimura S; Muramoto N; Nakahata H; Kubo S; Shimoyama Y; Kajiwara M; Echizen H J Chromatogr B Biomed Sci Appl; 1997 Nov; 701(1):71-80. PubMed ID: 9389340 [TBL] [Abstract][Full Text] [Related]
20. Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide. Bredesen JE; Kierulf P Br J Clin Pharmacol; 1984 Nov; 18(5):779-84. PubMed ID: 6508986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]